Multiple
Sclerosis (MS) Drugs
|
|
|
Copaxone
®
|
(interferon beta-1a)
|
| |
MS Drugs - Copaxone ® Efficacy
|
(Effectiveness of Copaxone ®)
|
| |
How effective is Copaxone ®?
|
|
% of patients relapse free at
2 years
|
|
Placebo
|
Copaxone ®
|
| 27 % |
34 %
|
|
| |
| |
|
Number of patients progression
free† completing 2 years of Copaxone
®
|
|
% of patients progression free at
2 years
|
Placebo
|
Copaxone ®
|
| 75 % |
78 % |
|
| |
| |
|
Mean relapse rate
|
|
Mean relapse rate over 2 years
|
Placebo
|
Copaxone ®
|
|
1.68
|
1.19
|
|
| |
| |
|
Average time to first relapse
|
|
Average number of days till first
relapse
|
Placebo |
Copaxone ® |
|
198 days
|
287 days
|
|
| |
| |
| † Progression is defined
as an increase in at least 1 point in the DSS (Kurtzke Expanded Disability
Scale) for at least 3 consecutive months |
| Ref: Copaxone® prescribing information
|
| |
| |
| Reviewed July 2004 |
|
|
